Infectious Disease

Preventive Cardiology

Questions discussed in this category

Would you recommend starting a moderate-intensity statin in a patient under the age of 40 years old with HIV and a 10-year ASCVD risk estimate below 5%?

The REPRIEVE trial included participants who were between 40 and 75 years old.

1 Answer available

Related Topics in Infectious Disease